Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zoledronic acid for osteoporosis in chronic stroke patients
jRCT1031190091Completed
- Start
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Single-arm trial of zoledronic acid in osteoporosis. Primary endpoint: Bone Mineral Density change at lumbar spine and bilateral femoral necks. Started Sep 2019; status: completed.
02
Drugs
zoledronic acid
03
Conditions
osteoporosis
Beyond the preview
Go deeper on jRCT1031190091.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1031190091.